PD0166285

CAS No. 185039-89-8

PD0166285( PD0166285 | PD 0166285 | PD0166285 )

Catalog No. M17395 CAS No. 185039-89-8

PD0166285 is a potent Wee1 and Chk1 inhibitor with activity at nanomolar concentrations.PD0166285 is a novel G2 checkpoint abrogator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 66 In Stock
5MG 119 In Stock
10MG 189 In Stock
25MG 416 In Stock
50MG 610 In Stock
100MG 869 In Stock
500MG 1737 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PD0166285
  • Note
    Research use only, not for human use.
  • Brief Description
    PD0166285 is a potent Wee1 and Chk1 inhibitor with activity at nanomolar concentrations.PD0166285 is a novel G2 checkpoint abrogator.
  • Description
    PD0166285 is a potent Wee1 inhibitor and Chk1 inhibitor with activity at nanomolar concentrations. This G2 checkpoint abrogation by PD0166285 was demonstrated to kill cancer cells, there at a toxic highest dose of 0.5 muM in some cell lines for exposure periods of no longer than 6 hours. The deregulated cell cycle progression may have ultimately damaged the cancer cells. We herein report one of the mechanism by which PD0166285 leads to cell death in the B16 mouse melanoma cell line.
  • In Vitro
    PD0166285 (0.5 μM) dramatically inhibits irradiation-induced Cdc2 phosphorylation at the Tyr-15 and Thr-14 in seven of seven cancer cell lines.PD0166285 sensitizes radiation-induced cell killing in p53 mutant HT29 cells and in the E6-transfected, p53-null ovarian cancer cell line PA-1 but to a lesser extent in p53 wild-type PA-1 cells. PD0166285 abrogates irradiation-induced G2 arrest and significantly increases mitotic cell populations. PD0166285 acts as a radiosensitizer to sensitize cells to radiation-induced cell death with a sensitivity enhancement ratio of 1.23. Western Blot Analysis Cell Line:Human and mouse cancer cell lines (HCT116, HT29, DLD-1, HCT8, H460, HeLa, C 26).Concentration:0.5 μM.Incubation Time:4 h.Result:Inhibited Cdc2Y15 and CdcT14 phosphorylation.
  • In Vivo
    Animal Model:Wild-type, Abcg2-/-, Abcb1a/b-/- and Abcb1a/b;Abcg2-/- FVB mice.Dosage:5 mg/kg.Administration:IV.Result:Cmax is about 400 ng/mL. P-gp, but not BCRP, limited the brain penetration of PD0166285.
  • Synonyms
    PD0166285 | PD 0166285 | PD0166285
  • Pathway
    GPCR/G Protein
  • Target
    GPCR19
  • Recptor
    Wee1| Chk1| Myt1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    185039-89-8
  • Formula Weight
    512.43
  • Molecular Formula
    C26H27Cl2N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 65 mg/mL 126.85 mM; H2O : < 0.1 mg/mL
  • SMILES
    CCN(CC)CCOc1ccc(Nc2nc3c(cn2)cc(c(=O)n3C)c2c(Cl)cccc2Cl)cc1
  • Chemical Name
    6-(2,6-dichlorophenyl)-2-((4-(2-(diethylamino)ethoxy)phenyl)amino)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wang Y, etal. Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator.[J]. Cancer Research, 2001, 61(22):8211-7.
molnova catalog
related products
  • BAR502

    BAR502 is a truncated side chain alcohol with both substituents on ring B in α-configuration.

  • SBI-115

    SBI-115 is an?antagonist of?TGR5.?SBI-115 decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5.

  • TC-G 1005

    TC-G 1005 is a potent and selective GPBA agonist (EC50 :0.72 nM; hTGR5). Selective for TGR5 over FXR (farnesoid X receptor). Increases plasma GLP-1 levels and reduces blood glucose in mice.